KAZIA THERAPEUTICS LTD, 2025-12-18
An SEC Form D private-offering notice from Sydney Nsw, a $55,251,088 filer-stated offering target in Biotech. Filed 2025-12-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Australian clinical-stage oncology company developing cancer therapies, including paxalisib for glioblastoma (brain cancer); listed on ASX and Nasdaq.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Ceretype Neuromedicine, Inc., 2025-12-18, $400K, Cambridge, MA
- InSitu Biologics, Inc, 2025-12-18, $8M, Oakdale, MN
- Paulex Bio Inc., 2025-12-18, $22.5M, La Jolla, CA
- Virax Biolabs Group Ltd, 2025-12-18, $5M, Lanarkshire
- Delfi Diagnostics, Inc., 2025-12-18, $60M, Palo Alto, CA
- Bio Usawa Inc., 2025-12-17, $1.7M, San Francisco, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.